Target Stores (NYSE: TGT) rocked the retail world on June 15 by announcing that it plans to sell all of its pharmacies and clinics to CVS Health (NYSE: CVS) for $1.9 billion. The deal is obviously a good one for CVS, which will get 1,600 pharmacies in 47 states and 80 clinics to operate, according to The New York Times, but how does Target benefit? That is a little hard to see because the nation's fourth largest discounter is moving into uncharted territory here. Allowing another retailer with a very different business model to come into your stores and operate a portion of your business is a risky strategy. The strategy is made all the riskier because on some level, Target and CVS are competitors. CVS operates small box discount stores in competition with Target's big boxes. Read more